Cahill represented the lead arrangers in the transaction.Horizon Therapeutics USA, Inc. executed its $1.6 billion incremental term B credit facility. Proceeds from the credit facility were used…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now